Background. The fibrinolytic system is part of the defense against thrombotic and cardiovascular events, but so far no study has shown that clinical measurements of fibrinolytic key components such as tissue plasminogen activator (t-PA) or plasminogen activator inhibitor type 1 (PAI-1) have any predictive value beyond 3 years.
T he involvement of the fibrinolytic system in the development and progression of acute myocardial infarction and unstable angina pectoris has been confirmed on the phenomenological level by studies using coronary angiography and angioscopy and by postmortem histopathological studies of cases of acute myocardial infarction and sudden cardiac death.
It is therefore reasonable to assume that measurements of components of the fibrinolytic system, such as tissue plasminogen activator (t-PA) or plasminogen activator inhibitor type 1 (PAI-1), could give an indication of the risk of cardiovascular events and/or mortality. Actually, there are only two truly prospective studies addressing these questions. Thus, in a study of young survivors of myocardial infarction, PAI-1 was found to predict 3-year reinfarction,' but in a longer follow-up (6 years) of the same patient group, the PAI-1 value could no longer predict events2; and in a 4-year follow-up of angina pectoris patients with angiographically verified coronary artery disease, we found t-PA mass concentration to be related to myocardial infarction, stroke, and other cardiovascular events, but PAI-1 activity was not. 3 Although the results from these two studies differ in details, they show that disturbances in the fibrinolytic system do predict future events in some patient groups. Note the interrelation between plasma levels of PAI-1 and t-PA, which is such that a low t-PA activity (which promotes thromboembolic events) concurs with high mass concentrations of t-PA in plasma because of enzyme inhibitor complex formation with PAI-1.
So far, there are no data at all on the ability of t-PA or PAI-1 to predict long-term mortality. We here report the relation of t-PA, PAI-1, and traditional risk factors in relation to mortality in a 7-year follow-up study of 213 patients with severe angina pectoris and angiographically verified coronary artery disease. The results have been presented in abstract form.4
Methods

Patients
This study is based on 248 consecutive patients ad- 
Sampling
Before coronary arteriography, blood samples were obtained in the early morning after an overnight fast for preparation of citrated plasma, which was assayed for mass concentration of t-PA with an ELISA method6 and for PAI-1 activity with a chromogenic substrate assay. 7 The reagents for these assays (Imulyse t-PA and Spectrolyse/Fibrin, respectively) were purchased from Biopool, Umea, Sweden. The details of these and other assays performed were given by Olofsson et al.5 Follow-up Study Protocol In March 1992, the patients' records were searched for death occurring after the day of coronary angiography. Death certificates were obtained for all who had died. No patient was lost to follow-up.
Statistical Analysis
Statistical analyses were performed by use of the SAS program.8 To illustrate the relation between a possible prognostic factor and the incidence of mortality, baseline variables were divided into quartiles, and the incidence of cardiovascular events in each quartile (Q through Q4) was calculated per 1000 patient-months. These quartiles were not used to test relations: for this, a Cox regression analysis was performed.9 Two-tailed tests were performed, and a value of P..05 was regarded as statistically significant. Relative risk (RR) was calculated as incidence of events in Q4 per incidence of events in Q1. Expert statistical advice was given by Kjell Pennert, Gothenburg.
Results
The mean follow-up time was 7 years. During this follow-up period, 33 patients died (15%). The life table for the proportion of subjects remaining alive is shown in Fig 1. Four patients died of malignancies, one of pneumonia, and 28 of cardiovascular disease.
In univariate Cox analyses with death as the response variable, t-PA mass concentration and ejection fraction were related to death (Table 2 ). To check whether the same risk relations also held true in a shorter time span after angiography, we performed the Cox regressions with 4 years as the maximum follow-up time, when only 19 patients had died ( Table 2) . As seen, t-PA mass concentration, ejection fraction, and age were related to death even over this shorter time span.
The subgroup that was subjected to coronary bypass surgery showed a pattern at 7-year follow-up similar to the total patient group, except that body mass index was also associated with the outcome. In this subgroup, only t-PA mass concentration and sex were related to mortality at the 4-year follow-up. Thus, only t-PA mass concentration consistently showed associations with mortality, both at 4-and 7-year follow-up, both in the total patient group and in the subgroup that was treated with coronary bypass. The number of deaths in quartiles 1 through 4 of t-PA mass concentration is shown in Fig 2. In were treatment for hypertension, sex, and smoking habits (never smoked, ex-smoker, current smoker). The RR (incidence of events in Q4 per incidence of events in Q1) for 7-year mortality in the total patient group was 3.85 with t-PA as the marker (Fig 2) . The RR to die within 7 years for a person who had been subjected to coronary bypass surgery because of severe angina pectoris was 9.9 times if the t-PA mass concentration was >11.5 lig/L (the lower limit of Q4) com- 
Discussion
This study shows for the first time that the fibrinolytic system is a major determinant of the long-term risk of dying among patients with severe angina pectoris. The mortality increased progressively through the quartiles of t-PA mass concentration (Fig 2) , but PAP-1 was unrelated in this study. Our findings are logical, considering that we have previously shown that a high t-PA mass concentration is predictive of the softer end points of myocardial infarction and stroke in this type of patient.3 The same predictive value of t-PA mass concentration was seen in the 78% of the subjects who were treated with coronary bypass surgery. These findings thus harmonize well with our previous study documenting the relation of t-PA mass concentration to cardiovascular events. 3 It is true that intuitively one would like to believe that higher levels of the "good" enzyme, t-PA, were related to a reduced, not to an increased, risk; throughout the 1970s it was common to speak of "a deficiency of fibrinolytic activity" as one of the causes for early-onset thrombosis (see, for example, the review by Hedner and Nilsson10). However, at that time it was not yet known that there is a complicated interplay between fibrinolytic activators and several plasma inhibitors (see Fig 3) . metabolic factors'8"9 may affect the activity of the fibrinolytic system in the individual, it has proved to be quite difficult to manipulate this system by nonpharmacological methods'9 or by drugs, although recent studies on, for instance, oral antidiabetics, cholestyramine, and doxazosin showed some encouraging results.20 In the subset of obese patients with the "metabolic syndrome" and hypofibrinolysis caused by high PAI-1 levels,'8 jejunoileal bypass surgery was shown to have a PAI-1-lowering effect that persists for more than one decade after surgery.21,22 Therefore, it may be possible in the future to actually improve the t-PA and/or PAI-1 levels in patients with unfavorable levels of these factors.
To conclude, we found that the levels of factors of the endogenous fibrinolytic system can predict not only soft end points but also mortality. If this can be confirmed in other clinical studies, we will have an increased incentive to go a step further and test whether treatment modalities that manipulate the regulation of these factors can actually improve long-term mortality. These are important areas for future studies.
